Ameliorating Effect of Yifei Tongluo Prescription on Bleomycin-induced Pulmonary Fibrosis in Rats via Regulating NLRP3/Caspase-1/GSDMD Signaling Pathway and Epithelial-mesenchymal Transition
|更新时间:2025-12-04
|
Ameliorating Effect of Yifei Tongluo Prescription on Bleomycin-induced Pulmonary Fibrosis in Rats via Regulating NLRP3/Caspase-1/GSDMD Signaling Pathway and Epithelial-mesenchymal Transition
“The latest research has found that Yifei Tongluo Formula can effectively improve pulmonary fibrosis by regulating the NLRP3/Caspase-1/GSDMD signaling pathway, reducing pro-inflammatory and pro fibrotic factors, and alleviating cell necrosis and EMT processes.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 32, Issue 1, Pages: 150-159(2026)
ZHOU Bowen,LI Zefeng,MA Xian,et al.Ameliorating Effect of Yifei Tongluo Prescription on Bleomycin-induced Pulmonary Fibrosis in Rats via Regulating NLRP3/Caspase-1/GSDMD Signaling Pathway and Epithelial-mesenchymal Transition[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(01):150-159.
ZHOU Bowen,LI Zefeng,MA Xian,et al.Ameliorating Effect of Yifei Tongluo Prescription on Bleomycin-induced Pulmonary Fibrosis in Rats via Regulating NLRP3/Caspase-1/GSDMD Signaling Pathway and Epithelial-mesenchymal Transition[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(01):150-159. DOI: 10.13422/j.cnki.syfjx.20250940.
Ameliorating Effect of Yifei Tongluo Prescription on Bleomycin-induced Pulmonary Fibrosis in Rats via Regulating NLRP3/Caspase-1/GSDMD Signaling Pathway and Epithelial-mesenchymal Transition